Bio-Rad Laboratories BIO Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's total current liabilities?
- Bio-Rad Laboratories (BIO) reported total current liabilities of $917M in Q1 2026.
- How has Bio-Rad Laboratories's total current liabilities changed year-over-year?
- Bio-Rad Laboratories's total current liabilities increased by 81.0% year-over-year, from $506.6M to $917M.
- What is the long-term trend for Bio-Rad Laboratories's total current liabilities?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's total current liabilities has grown at a -3.9% compound annual growth rate (CAGR), from $631.54M to $517M.
- What does total current liabilities mean?
- The total amount of debt and obligations the company must pay within the next twelve months.
- How do you interpret total current liabilities?
- A high ratio relative to current assets may indicate liquidity risk, while a stable or decreasing trend suggests strong short-term financial health.
- How does total current liabilities compare across companies?
- Used universally to calculate the current ratio and assess short-term solvency.